Bratha

Part 3.1 — Neural Preservation Compounds

17 min read

This is Part 3 of 4 in the Cognitive Enhancement Series (the hardware you protect). The full path:

  • Part 1 — Foundation (2 sub-articles):
  • Part 2 — The Base:
    • Part 2.0: The Behavioral Base (the 90% that comes before any compound, and where it ladders in your life)
  • Part 3 — Pharmacology (2 sub-articles):
  • Part 4 — Application (4 sub-articles):

Table of Contents

The unglamorous half

Nobody posts about their neuroprotection stack. There’s no immediate feeling: Memantine doesn’t give you a great afternoon the way modafinil does. That’s exactly why this bucket gets skipped, and exactly why skipping it is the expensive mistake. Preservation is the joint care of the brain: invisible while it's working, catastrophic when you find out you needed it. If Part 3.0 is the software you run hot, this is the hardware that determines whether you can keep running it at 45 the way you do at 25.

Why this bucket is the one you’ll skip and regret

The whole logic of the architecture is that Performance is a loan and Preservation is the repayment. Every hard, stimulated, under-slept working day spends something: receptor sensitivity, glutamate balance, structural reserve. If you only ever run Bucket A, the bill arrives as tolerance (your stimulants stop working), then as a flatter, foggier baseline, then, over a long enough horizon, as real decline.

This bucket is also where your existing PE harm-reduction discipline transfers directly: a brain is a vascular, hormonal, inflammatory organ, and the same things that protect your heart and arteries on cycle protect your brain, which is why your standard blood panel doubles as part of your brain panel.

Pillar 1: Neurogenesis & Neurotrophic Factors (BDNF / NGF)

The “muscle growth” of the brain: structural adaptation that lets you retain what you learn and physically reshape circuitry. These act over weeks to months, never acutely. Judge them on your slow-moving verbal-memory PR, not on how you feel today.

The biggest BDNF lever is free

Before any compound: aerobic exercise is the most reliable known driver of BDNF. The Athletic series base-building work is, mechanistically, a neurogenesis protocol. No supplement in this pillar out-performs a consistent cardio habit; they layer on top of it.

Tier 1: Clinical Essentials

  • None. There is no approved drug for general healthy neurogenesis. (This absence is itself informative: the bottle that “grows new brain cells in healthy adults” doesn’t exist as a regulated medicine.)

Tier 2: Premium OTC

  • Lion’s Mane (Hericium erinaceus), dual-extract: its compounds hericenones and erinacines stimulate NGF synthesis, and that mechanism is well-established in vitro and in animals.1 Human cognitive trials are smaller and mixed, with the most convincing result in older adults with mild cognitive impairment (Mori 2009, ~3 g/day dried powder over 16 weeks, improving progressively then regressing after stopping). Treat it as promising and well-tolerated, not as proven for a healthy young brain, and give it months, since the whole mechanism is slow. Pairs well with Bacopa for long-term structural support (see Part 4.1).
  • Polygala tenuifolia (Yuan Zhi): ~100–300 mg of a standardised root extract. A TCM herb that up-regulates BDNF and NGF and supports acetylcholine in animal and early human work.2 It’s the stronger natural neurogenesis option than Lion’s Mane (the “ceiling-breaker” from Part 4.1), but the evidence is preliminary, so treat it as promising rather than proven, and reach for it only after Lion’s Mane has had its months.

Tier 3: Experimental

  • Noopept: a synthetic peptide-derived compound that up-regulates BDNF and NGF in animal models and is widely used as a nootropic. Real mechanism, limited human data, generally well-tolerated at low doses (10–30 mg).
  • Semax: a synthetic peptide (nasal spray), Russian-developed, reported to spike BDNF and protect brain tissue. Interesting, minimal Western safety data.
  • Cerebrolysin: an injectable mixture of purified neuropeptides used clinically (outside the West) for stroke and dementia recovery. Heavy-duty, genuinely neurotrophic, and not a casual nootropic; it’s a parenteral drug for serious indications. Listed for completeness; firmly not a self-experimentation item.

Pillar 2: Glutamate Regulation & Neuroprotection

The “joint and system care.” Glutamate is the brain’s main excitatory signal: necessary to think, toxic in excess. Chronic stress, sleep deprivation, and heavy stimulant use push it toward excitotoxicity, where over-excited neurons damage themselves. This pillar shields against that.

This is also the home of your systemic biomarkers (lipids, glucose, blood pressure, and hs-CRP), pulled straight from the PE blood panel, because a brain is a vascular, inflammatory organ and what’s bad for your arteries is bad for your cognition.

One clarification on hs-CRP, since it's easy to misread

==hs-CRP is a systemic inflammation marker that predicts brain risk, not a direct readout of brain inflammation.== It’s made by the liver (chiefly in response to IL-6) and is a peripheral number. Elevated CRP does track higher risk of cognitive decline, dementia, and stroke, and CRP/IL-6 turn up in Alzheimer’s plaques, so it’s a legitimate warning light. But its correlation with direct microglial-neuroinflammation markers is inconsistent: a normal hs-CRP doesn’t certify a quiet brain, and a high one only localises the problem to “somewhere in the body.” Genuinely measuring brain inflammation needs CSF or PET, not a blood draw.3 Practical reading: treat it as a risk predictor and drive it low with the same levers that protect your heart: sleep, cardio, omega-3, glycaemic control, not over-doing stimulants. The protective moves overlap.

Tier 1: Clinical Essentials

  • Memantine (Namenda): an uncompetitive NMDA-receptor antagonist. The elegance is in the mechanism: it sits on the NMDA receptor like a shield, blocking the excessive, toxic glutamate surges while still letting normal, healthy signalling pass through, which is why it doesn’t blunt baseline learning the way a blunt NMDA blocker would. Approved for Alzheimer’s; some enhanced users run it specifically to buffer stimulant excitotoxicity.

    Memantine has a real performance trade-off acute edge and even slightly flatten the "reward" of intense focus for some people. It's a preservation tool, not a performance one; adding it might make a high-stimulant day feel less sharp even as it protects you. Know which bucket you're optimising before you add it.

    By dampening glutamate, Memantine can blunt the

Tier 2: Premium OTC

  • Magnesium L-Threonate: ~1.5–2 g (delivering ~144 mg elemental Mg): the one magnesium form shown to efficiently cross the blood-brain barrier and sit on NMDA receptors, gently modulating glutamate. Most people are mildly magnesium-deficient anyway, making this a low-risk, sensible base. (Also mildly supports sleep, overlapping with the Sleep series.)
  • NAC (N-Acetyl-Cysteine): ~600–1,200 mg. Regulates the glutamate cycle and is the direct precursor to glutathione, the brain’s master antioxidant, so it clears neuro-inflammatory oxidative load while balancing glutamate. One of the better-evidenced, lowest-risk neuroprotective supplements, and useful to the enhanced lifter for liver and antioxidant support too.

Tier 3: Experimental

  • Emoxypine (Mexidol): a Russian-pharmacopoeia antioxidant/membrane-stabiliser (a vitamin-B6 structural analogue) used for ischemia and stress protection. Reasonable mechanism, essentially no Western trial base.

Pillar 3: The Neurosteroid Base (Pregnenolone / DHEA)

This is the pillar that matters most to you specifically, because you run exogenous testosterone, and it’s the one most enhanced lifters never connect.

The mechanism, fact-checked carefully

Neurosteroids are steroids made in the brain that rapidly modulate neurotransmitter receptors. But the popular framing needs a correction:

Pregnenolone itself is largely inactive at the receptor; it's the metabolites that do the work

The common claim that “pregnenolone is a positive modulator of NMDA receptors” is imprecise. Pregnenolone itself has little direct GABA-A or NMDA activity; it’s the sulfated metabolite, pregnenolone sulfate (PregS), that is a positive allosteric modulator of NMDA and a GABA-A antagonist.4 Note what that means: PregS is net excitatory/pro-arousal, not a calming agent, the opposite of how it’s sometimes sold. DHEA’s sulfate (DHEAS) behaves similarly (potentiates NMDA, inhibits GABA-A), and both are neuroprotective in models.4 Pregnenolone’s real role for you is as the upstream precursor to the whole downstream cascade.

Why it matters when you’re on cycle

When you run exogenous testosterone or heavier blasts, your natural endocrine loop shuts down. That shutdown can suppress the upstream steroids, pregnenolone and DHEA, because the body throttles back the precursor machinery. The result is the thing a lot of enhanced lifters describe and can’t explain:

Brain fog, low stress tolerance, and emotional flatness even when serum testosterone is sky-high. It’s not a testosterone problem (more test won’t fix it); it’s a depleted neurosteroid base. This is why some enhanced lifters “backfill” with exogenous pregnenolone/DHEA to restore the brain’s internal chemistry. It connects directly to the neuroprotection ancillaries discussion in the PE series.

Tier 1: Clinical Essentials

  • None for optimisation. Medicine doesn’t prescribe neurosteroids for general cognition. (The one approved relative, brexanolone, is an allopregnanolone formulation used as an inpatient infusion for postpartum depression, not remotely a nootropic.)

Tier 2: Premium OTC (base restoration)

  • Pregnenolone: the “grandmother hormone,” precursor to the entire downstream steroid cascade. Used by enhanced lifters specifically to backfill what a cycle suppresses. Approach as a hormone, not a vitamin; see the warning below.
  • DHEA: works alongside pregnenolone to maintain the brain’s hormonal balance and buffer cortisol-driven neuronal damage. The catch: DHEA converts downstream into androgens and oestrogens more readily than pregnenolone does, so it can cause systemic hormonal swings, particularly unwanted if you’re already managing oestrogen on cycle. If choosing one for pure cognition, pregnenolone is usually the cleaner pick.

Neurosteroids are not supplements; they're hormones

Unlike an amino acid or a vitamin, these shift your hormonal baseline directly. Taken without a confirmed deficit, they can suppress your own production and cause mood and hormonal swings. The right way to use them mirrors the PE series’ whole philosophy: test, don't guess. Get pregnenolone/DHEA (and your full hormonal panel) measured, use them to correct a demonstrated deficit (especially the cycle-induced kind) and re-test. Blind supplementation of a potent hormone “for focus” is exactly the unstructured move this series exists to replace.

Tier 3: Experimental

  • Ganaxolone: a synthetic analogue of allopregnanolone, in research for targeted, non-sedating GABA-A modulation (and approved in a narrow seizure indication). Not a general cognitive tool.

Uridine: the synaptic sculptor that bridges both buckets

Uridine deserves a dedicated note because it sits across the Performance/Preservation line, and because the forums “swear by it,” usually to repair a brain burnt out by chronic stimulants. Uridine monophosphate, ~150–300 mg, is an OTC nucleotide.

  • The solid claim, structural (Preservation): uridine is a precursor to phosphatidylcholine, the main component of brain-cell membranes, built via the Kennedy (CDP-choline) pathway. That pathway needs three substrates together (==uridine + choline + DHA==), and it’s only when all three are present that you get the documented jump in synaptic membranes and dendritic spines (the “Mr Happy Stack” mechanism, Wurtman et al.).5 Uridine without omega-3 and choline is two-thirds of a recipe. This is why the dietary omega-3 base isn’t optional garnish; it’s a co-limiting ingredient of the very mechanism that makes uridine worth taking. (CDP-choline conveniently supplies the choline leg itself.) This is the part of uridine you can bank on.
  • The shakier claim, dopamine receptors (Performance): the popular idea that uridine “increases D2 receptor density” to restore dopamine sensitivity after stimulant down-regulation comes from animal studies, and even those are mixed (some show D1 up and D2 down). Treat the "restores your dopamine receptors" pitch as a plausible, animal-level hypothesis, not an established human effect. The membrane-building is the part you can bank on.
  • How to use it: a daily, long-horizon compound (like the BDNF agents), best stacked with a choline source and omega-3. You don’t feel it in two hours; you run it for months to raise structural capacity. It anchors the natural stack in Part 4.1.

The supporting cast: energy, blood flow, and membranes

A few of the natural-stack staples don’t belong to any single one of the six pathways. Like uridine above, they’re cross-cutting infrastructure: the energy, the plumbing, and the building material that let every pathway actually run. They sit in this Preservation article because they’re protective in spirit (they keep the hardware working), but they serve both buckets.

  • Creatine monohydrate (3–5 g daily): the brain’s ATP buffer. It recycles cellular energy so neurons don’t brown out under heavy or sleep-deprived cognition, and it’s one of the better-evidenced, lowest-risk cognitive supplements.2 The cognitive dose is 3–5 g, not the 20 g athletic loading dose. Pairs with ALCAR on the mitochondrial-energy side.
  • Ginkgo Biloba (120–240 mg): a mild cerebral vasodilator. It widens blood vessels to improve the blood flow that delivers oxygen (and every other compound) to the prefrontal cortex, the “logistics” of the stack. The human cognitive evidence is modest, so treat it as a reasonable, low-risk delivery aid, not a hero, and note the bleeding/anticoagulation caution.
  • Phosphatidylserine (100–300 mg): a structural phospholipid of neuronal membranes that also helps blunt cortisol spikes. It supports the same membrane-building the uridine trinity drives, and smooths the edge off caffeine alongside L-theanine.
  • Omega-3 (DHA) (≥500–1,000 mg DHA): the foundational structural fatty acid of every membrane, and the third leg of the uridine + choline trinity above. It earns a place on this list in its own right; the full dietary case is in Part 2.0.

Why these are here and not in the "six levers"

Cataloguing them keeps the natural stack honest: every compound in that engine should be findable here with a mechanism, even the ones that aren’t neurotransmitter levers. These four are support systems, energy, circulation, and structure, rather than a dial you turn for an acute effect.

The Preservation stack at a glance

PillarTier 1 (Clinical)Tier 2 (Premium OTC)Tier 3 (Experimental)
Neurogenesis (BDNF/NGF)None (cardio is the lever)Lion’s Mane (dual-extract) · Polygala tenuifoliaNoopept · Semax · Cerebrolysin (parenteral)
Glutamate / NeuroprotectionMemantineMagnesium L-Threonate · NACEmoxypine
Neurosteroid BaseNonePregnenolone · DHEA (test first)Ganaxolone
Structural (bridge)NoneUridine monophosphate (+choline +DHA)—
Supporting cast (energy/flow/membrane)NoneCreatine · Ginkgo · Phosphatidylserine · Omega-3—
Systemic biomarkers(managed via the PE panel)omega-3, glycaemic control, sleep, cardio—

The preservation principle

==The best neuroprotection isn’t a Tier-3 peptide; it’s sleep, cardio, omega-3, stable glucose, and not running Bucket A past what your hardware can repay.== The compounds here are the margin on top of that, and the neurosteroids specifically are a test-driven correction for the deficit a cycle creates, not a blind add.

Part 3 Takeaways

Key concepts to internalise

  • Performance is a loan; Preservation is the repayment. Run Bucket A without this and you pay in tolerance, fog, and eventual decline.
  • hs-CRP is a systemic marker that predicts brain risk, not a direct brain-inflammation reading. Keep it in the Healthy bucket; drive it low with the same levers that protect your heart.
  • Neurogenesis (BDNF/NGF) is slow and months-long; cardio is the biggest lever, Lion’s Mane is promising-not-proven, the peptides are Tier 3.
  • Glutamate regulation prevents excitotoxicity: Memantine (clinical, but blunts the acute edge), Mag-L-Threonate and NAC (low-risk OTC).
  • Neurosteroids matter most for you: a cycle can suppress pregnenolone/DHEA and cause “TRT brain fog” that more testosterone won’t fix. But it’s the sulfated metabolites that act on receptors, PregS is pro-arousal not calming, and these are hormones: test, correct, re-test.
  • Uridine bridges both buckets: solid for synaptic membrane-building, but only as a trinity with choline + DHA (the Kennedy pathway needs all three; omega-3 is co-limiting, not optional), and shaky on the “restores D2 receptors” claim.

Up next

You now have the full toolbox: both buckets, all three tiers. Part 4.1 — The Natural Stack assembles the Tier-2 layer into a real daily engine: the bio-circuit storyline, optimised doses, the synergy-and-redundancy map, a dynamic timing strategy, a two-tier daily/heavy-day protocol, and a full Malaysian cost model. Then Part 4.2 — The Enhanced Stack shows what changes when you layer experimental and prescription compounds on top.

Disclaimer

This article is educational and is not medical advice. Memantine and ganaxolone are prescription medications; pregnenolone and DHEA are potent hormones that alter your endocrine baseline and should only be used under medical supervision with bloodwork, particularly by anyone on exogenous androgens. Research peptides (Noopept, Semax, Cerebrolysin) lack long-term human safety data. Persistent brain fog or cognitive decline warrants medical evaluation; it has many treatable causes. Consult a qualified doctor.

Sources & references

Footnotes

  1. Mori, K. et al. (2009), “Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial,” Phytotherapy Research 23(3):367–372. Cognitive improvement over 16 weeks that regressed after cessation. Mechanistic NGF induction via hericenones/erinacines: Lai, P.-L. et al. (2013), International Journal of Medicinal Mushrooms 15(6):539–554. Human cognitive evidence overall remains small and mixed; the Alzheimer’s Drug Discovery Foundation’s Cognitive Vitality review flags the need for larger trials. ↩

  2. Creatine: Avgerinos, K.I. et al. (2018), “Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials,” Experimental Gerontology 108:166–173 (supports short-term memory and reasoning, clearest under stress such as sleep deprivation; cognitive dosing 3–5 g/day). Polygala tenuifolia: up-regulation of BDNF/NGF and pro-cholinergic, memory-protective effects shown in animal and cell work (e.g. polygalasaponins reversing scopolamine-induced memory deficits in rodents); human cognitive evidence remains preliminary. ↩ ↩2

  3. On hs-CRP as a systemic (hepatic, IL-6-driven) inflammation marker and its association with cognitive decline, dementia and stroke via blood-brain-barrier crossing, plus the presence of CRP/IL-6 in AD pathology: see review and cohort evidence summarised in Frontiers in Aging Neuroscience (2023), “Impact of hs-CRP concentration on brain structure alterations and cognitive trajectory in Alzheimer’s disease” PMC10427872; and Tegeler/Locascio-type analyses showing the correlation between systemic hs-CRP and direct microglial neuroinflammation markers is inconsistent. Direct CNS inflammation is assessed via CSF markers or TSPO-PET, not serum CRP. See also Perry, V.H. & Holmes, C. (2014), “Microglial priming in neurodegenerative disease,” Nature Reviews Neurology 10:217–224 on systemic-to-central inflammatory signalling. ↩

  4. Reddy, D.S. (2010) and Smith, C.C. et al. (2014), reviews of neurosteroid receptor pharmacology: pregnenolone sulfate (PregS) is a positive allosteric modulator of NMDA receptors and a GABA-A antagonist (net excitatory), while pregnenolone itself lacks significant direct GABA-A/NMDA activity; DHEAS potentiates NMDA and inhibits GABA-A. See “Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders,” Frontiers in Endocrinology (2019) PMC6465949. Human cognition RCTs of pregnenolone are limited and have shown null effects on memory/executive function in at least one (underpowered) trial; the optimisation case rests largely on correcting a demonstrated deficit. ↩ ↩2

  5. Wurtman, R.J. et al. (2009), “Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus DHA orally,” Brain Research 1264:130–140. Uridine + DHA + choline increases synaptic membrane synthesis and dendritic spine density (the “Mr Happy Stack” basis). The dopamine D2-receptor-density / DAT claims derive from rodent work (e.g. striatal studies) and are inconsistent (some show D1↑/D2↓); not established in humans. Typical uridine monophosphate dosing 150–300 mg/day. ↩

Graph View

Backlinks